Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3015479	b-tbevi	— (—)	679	1060	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Bacterial infection, other or unspecified, including avohilmo

315

188

13.84

302.49

1.7

1.4

—

Fever of other and unknown origin

309

205

13.16

298.69

1.6

1.4

—

Bacterial infection, other or unspecified

304

186

13.91

298.01

1.7

1.4

—

Other bacterial diseases

359

243

9.83

249.00

1.7

1.4

—

Other bacterial diseases, including avohilmo

343

232

9.27

221.32

1.7

1.4

—

Liquid cancers

202

142

13.63

209.59

1.7

1.5

—

Liquid cancers, including Hilmo

216

162

11.87

198.54

1.8

1.5

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

335

319

7.11

186.07

1.6

1.5

—

Primary_lymphoid and hematopoietic malignant neoplasms

179

150

12.11

178.34

1.7

1.5

—

Other septicaemia

177

137

12.27

172.67

1.7

1.5

—

Other septicaemia, including avohilmo

180

144

11.82

171.11

1.7

1.5

—

Septicaemia

187

154

11.15

168.58

1.6

1.5

—

Pneumonia, organism unspecified

288

297

6.67

153.23

1.7

1.4

—

Pneumonias (Asthma/COPD co-morbidities)

302

305

6.49

153.12

1.7

1.5

—

All pneumoniae

302

313

6.29

148.64

1.7

1.5

—

ILD medications: immunosuppressive drugs

221

268

7.50

148.07

1.8

1.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

298

323

6.16

145.79

1.7

1.5

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

270

215

7.37

143.18

1.7

1.4

—

270

215

7.37

143.18

1.7

1.4

—

Influenza and pneumonia

299

301

6.15

140.67

1.7

1.4

—

Explicit Sepsis, including avohilmo

195

232

7.67

133.05

1.7

1.5

—

Explicit Sepsis

192

227

7.75

132.50

1.7

1.5

—

Transplanted organ and tissue status

20.87

126.89

1.9

1.6

—

Infections, IBD-co-morbidities

105

23.31

112.73

2.1

1.3

—

ILD medications

284

285

5.38

110.79

1.8

1.4

—

Bacterial Sepsis

189

234

6.71

110.38

1.6

1.5

—

Implicit bacterial Sepsis

175

212

7.12

109.39

1.6

1.5

—

Implicit bacterial Sepsis, including avohilmo

184

229

6.72

107.85

1.6

1.5

—

ILD medications: prednisolone, methylprednisolone, prednisone

273

284

5.36

107.61

1.7

1.4

—

First line medication for Crohn's disease

265

273

5.23

100.58

1.7

1.4

—

Certain infectious and parasitic diseases

196

131

7.51

96.73

1.7

1.3

—

Aplastic and other anaemias

177

291

5.59

90.33

1.6

1.5

—

Non-Hodgkin lymphoma, all, including Hilmo

14.39

89.51

1.8

1.6

—

Oral corticosteroids

265

357

4.36

86.19

1.7

1.5

—

Other diseases of blood and blood-forming organs, wide

112

137

8.25

84.90

1.8

1.5

—

Other anaemias

161

275

5.51

81.54

1.6

1.5

—

Other and unspecified anaemias

160

274

5.51

81.16

1.6

1.5

—

Enlarged lymph nodes

13.04

78.42

1.8

1.5

—

Inflammatory bowel disease treatment related agents

265

362

4.07

77.57

1.7

1.5

—

General symptoms and signs

218

217

5.04

77.18

1.6

1.5

—

Renal tubulo-interstitial diseases

224

390

4.22

76.44

1.6

1.5

—

Any gastric operation

128

9.60

74.02

1.6

1.3

—

GASTRO-related operations

128

9.60

74.02

1.6

1.3

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

235

366

4.07

72.48

1.6

—

All kidney diseases

232

389

4.00

71.75

1.5

1.6

—

Implicit Sepsis

194

320

4.48

71.38

1.6

1.5

—

Anaemias

20.43

70.06

1.9

1.6

—

COPD/asthma/ILD related infections

205

215

4.79

68.90

1.7

1.4

—

COPD/asthma related infections

205

215

4.79

68.90

1.7

1.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

195

412

4.13

68.73

1.7

1.4

—

Implicit viral Sepsis

104

8.43

67.20

1.8

1.5

—

Viral Sepsis

104

8.43

67.20

1.8

1.5

—

Implicit viral Sepsis, including avohilmo

104

153

6.82

66.88

1.8

1.5

—

Certain infectious and parasitic diseases, including avohilmo

129

7.71

65.01

1.6

1.3

—

L04AD Calcineurin inhibitors

10.59

63.90

2.1

1.6

—

Implicit Sepsis, including avohilmo

194

337

4.12

63.82

1.6

1.5

—

Myeloid leukaemia

20.91

62.92

1.8

1.4

—

Dialysis, with operation codes

8.91

59.62

1.8

1.6

—

Nephropathy related operations

9.01

59.30

1.8

1.5

—

Abnormal findings on diagnostic imaging of lung

156

350

4.24

58.46

1.7

1.5

—

Persons encountering health services for specific procedures and health care

228

375

3.59

58.38

1.6

1.5

—

Any death

184

329

3.93

56.43

1.7

1.4

—

Secondary and unspecified malignant neoplasm of lymph nodes

14.89

56.23

1.7

1.2

—

Renal failure

155

315

4.21

55.65

1.6

1.5

—

Heart failure, not strict

193

345

3.77

55.33

1.6

1.5

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

187

333

3.80

54.25

1.6

1.5

—

Autoimmune diseases related-to ILD

191

451

3.54

53.86

1.7

1.5

—

Malignant neoplasm

178

256

4.08

53.69

1.6

1.5

—

Malignant neoplasm

178

256

4.08

53.69

1.6

1.5

—

Condition for Implicit Sepsis (Organ dysfunction codes)

185

341

3.76

53.56

1.6

1.5

—

Malignant neoplasm, including Hilmo

178

256

4.06

53.20

1.7

1.5

—

All chronic kidney diseases

150

284

4.22

52.99

1.6

1.5

—

Malignant neoplasm, wide definition

178

257

4.04

52.90

1.6

1.5

—

Tuberculosis, IBD comorbidity

11.18

52.01

2.0

1.3

—

Care involving dialysis

13.90

51.93

1.8

1.7

—

Secondary uncertain malignant neoplasm

9.76

51.84

1.6

1.5

—

Acute renal failure

160

5.79

50.43

1.5

1.6

—

Agranulocytosis

9.19

49.52

1.7

1.3

—

L04AX Other immunosuppressants

144

368

3.92

49.51

1.8

1.5

—

Tuberculosis, wide

10.34

49.35

2.0

1.3

—

Diffuse large B-cell lymphoma, including Hilmo

16.73

48.80

1.6

1.1

—

Diffuse large B-cell lymphoma, helper endpoint

16.73

48.80

1.6

1.1

—

Diffuse large B-cell lymphoma

16.73

48.80

1.6

1.1

—

Tuberculosis, wide, including avohilmo

10.15

48.71

2.0

1.3

—

Second line medication for Crohn's disease

146

381

3.84

48.71

1.8

1.5

—

Other medical care

136

272

4.21

48.71

1.5

1.6

—

Any event in cancer register

178

279

3.73

47.90

1.6

1.5

—

Other pulmonary diagnosis

131

127

5.18

47.82

1.6

1.5

—

Acute myeloid leukaemia and myelodysplastic syndromes

64.66

47.80

1.9

1.2

—

COPD differential diagnosis

131

128

5.14

47.47

1.6

1.5

—

ILD differential diagnosis

131

128

5.14

47.46

1.6

1.5

—

Excluding asthma or asthma-COPD overlap

130

127

5.14

47.11

1.6

1.5

—

Non-follicular lymphoma

8.16

46.54

1.7

1.4

—

Fungal Sepsis

17.97

45.56

2.0

1.5

—

L04AA Selective immunosuppressants

141

5.85

45.51

2.2

1.5

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

8.14

44.36

1.9

1.6

—

Systemic connective tissue disorders

107

238

4.52

44.32

1.5

1.6

—

Complications of surgical and medical care, not elsewhere classified

209

454

3.08

44.30

1.7

1.5

—

Other heart diseases

113

5.65

44.11

1.4

1.5

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

10.34

44.01

1.5

1.4

—

Chronic kidney disease

107

229

4.52

43.77

1.7

1.5

—

Erysipelas, including avohilmo

125

218

4.25

43.58

1.5

1.4

—

Thrombocytopenia, unspecified

10.59

42.88

1.5

1.4

—

Oxycodone

120

247

4.17

42.76

1.5

1.6

—

Implicit fungal Sepsis, including avohilmo

12.97

42.60

2.0

1.4

—

Purpura and other haemorrhagic conditions

7.02

42.29

1.5

—

Asthma, unspecified (mode), excluding more controls

105

5.87

41.96

1.5

1.3

—

Other heart diseases, wide

168

295

3.45

41.20

1.5

1.6

—

Valvular operations

7.49

40.65

1.2

1.6

—

Malaise and fatigue

104

181

4.53

40.04

1.7

1.4

—

Non-Hodgkin lymphoma, all

15.49

40.03

2.2

1.2

—

Coagulation defects, purpura and other haemorrhagic conditions

132

5.64

39.56

1.5

1.6

—

Heart failure,strict

140

269

3.64

38.96

1.5

—

Other diseases of pleura

131

315

3.63

38.80

1.8

1.5

—

Asthma, unspecified (mode)

123

5.17

38.01

1.5

1.3

—

Lymphoid leukaemia

10.42

37.83

1.8

1.3

—

Erysipelas

100

200

4.32

37.48

1.4

—

Autoimmune diseases excluding thyroid diseases

200

368

2.95

37.05

1.7

1.5

—

Tuberculosis

9.30

36.57

2.0

1.4

—

Dental caries

153

4.95

36.40

1.9

1.6

—

Other viral diseases, including avohilmo

202

4.42

36.34

1.8

1.4

—

Other viral diseases

157

4.97

36.29

1.9

1.4

—

Autoimmune diseases excluding thyroid diseases, strict definition

194

359

2.94

35.88

1.7

1.5

—

Certain disorders involving the immune mechanism

122

5.53

35.08

1.8

1.5

—

ILD, hospital admission 2, with pulmonary infections

10.64

34.87

1.6

1.3

—

ILD medications: azathioprine

9.80

34.73

1.9

1.2

—

Enterocolitis due to Clostridium difficile

7.09

34.71

1.7

1.3

—

Viral pneumonia

8.39

34.69

1.5

1.3

—

Atrial fibrillation and flutter

5.50

34.60

1.3

1.5

—

Other necrotizing vasculopathies

8.89

34.57

1.5

1.4

—

Heart failure and antihypertensive medication

5.53

34.42

1.6

1.7

—

Caries of dentine

137

5.09

34.05

1.8

1.5

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

5.91

33.84

1.5

—

Valvular heart disease excluding rheumatic fever

112

209

3.84

33.82

1.3

1.6

—

Bacterial pneumoniae

177

4.38

33.77

1.6

1.4

—

Extracorporeal dialysis

9.44

33.61

1.6

—

Bacterial intestinal infections, IBD co-morbidities

114

5.56

33.21

1.7

1.4

—

All influenza

111

5.60

33.02

2.1

1.4

—

Other bacterial intestinal infections

122

5.36

32.94

1.7

1.5

—

Non-rheumatic valve diseases

110

207

3.80

32.81

1.3

1.6

—

Asthma, excluding more controls

108

4.66

32.74

1.5

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.07

32.61

2.4

1.5

—

Complications of medical and surgical care

155

480

2.91

32.55

1.7

1.5

—

Covid-19 confirmed case

259

3.79

32.29

1.7

1.5

—

Cardiac arrhythmias

101

161

4.03

31.30

1.4

1.5

—

Respiratory tuberculosis, confirmed and not-confirmed

9.87

31.24

1.8

1.4

—

Respiratory tuberculosis

9.87

31.24

1.8

1.4

—

ILD, hospital admissions 3, with pneumonia sepsis

8.92

30.69

1.6

1.3

—

Asthma

102

126

4.18

30.27

1.5

—

Bacterial pneumonia (organism specified)

109

291

3.40

29.80

1.6

—

Solid cancers, including Hilmo

138

257

3.13

29.04

1.6

1.5

—

Solid cancers

137

256

3.14

29.02

1.5

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

10.17

28.72

1.5

1.3

—

Asthma (mode)

128

4.07

28.69

1.4

1.5

—

Heart failure, strict

143

339

2.94

28.63

1.5

—

Polyarthropathies

141

302

3.00

28.63

1.7

1.6

—

Provisional assignment of new diseases of uncertain etiology

116

367

3.14

28.59

1.6

1.5

—

Codes for special purposes

116

367

3.14

28.59

1.6

1.5

—

Diseases of the respiratory system

116

4.20

28.58

1.6

1.5

—

Autoimmune diseases

191

368

2.64

28.56

1.7

1.5

—

Bacterial pneumonia, not elsewhere classified

161

4.21

28.21

1.6

1.4

—

Other bacterial intestinal infections, including avohilmo

156

4.44

28.15

1.6

1.5

—

Asthma (only as main-diagnosis), excluding more controls

108

4.41

28.00

1.5

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

130

439

2.91

27.99

1.7

1.5

—

Azathioprine

7.44

27.96

1.9

1.3

—

Acute tubulo-interstitial nephritis

117

314

3.15

27.85

1.5

—

All-cause Heart Failure

140

336

2.91

27.51

1.5

—

Myelodysplastic syndrome, including Hilmo

30.85

27.32

2.1

1.2

—

Asthma (only as main-diagnosis)

126

4.04

26.90

1.4

1.5

—

AV-block

5.42

26.75

1.4

1.6

—

Reimbursement for rheumatic diseases

113

371

3.03

26.31

1.8

1.5

—

190

381

2.53

26.29

1.6

1.5

—

Other disorders of white blood cells

9.80

25.91

1.6

1.4

—

Failure and rejection of transplanted organs and tissues

35.09

25.87

2.3

1.4

—

Bronchitis

187

460

2.44

25.35

1.6

1.5

—

Mycoses

205

3.77

25.27

1.8

1.5

—

Other/unspecified cytomegaloviral diseases

28.68

24.65

2.7

1.5

—

Neoplasms

107

165

3.41

24.65

1.7

1.4

—

Nutritional anaemias

109

349

2.98

24.46

1.6

—

Other respiratory diseases principally affecting the interstitium

136

4.44

24.46

1.6

—

Glomerular diseases

128

4.56

24.44

1.7

1.5

—

Other infectious diseases

7.36

24.17

2.1

1.4

—

Cytomegaloviral disease

23.48

24.03

2.7

1.4

—

Cytomegaloviral disease, including avohilmo

23.46

24.03

2.7

1.4

—

Other necrotizing vasculopathies (FG)

8.47

24.02

1.5

1.4

—

Hernia of abdominal wall, postoperative

8.78

23.94

1.3

—

Cytomegalovirus infection, IBD co-morbidity

22.04

23.59

2.7

1.3

—

Iron deficiency anaemia

308

3.10

23.38

1.6

—

Pleural effusion

107

4.79

22.86

2.0

1.5

—

Used for control exclusion in common control thyroid runs

169

342

2.49

22.78

1.7

1.5

—

Complications of procedures, not elsewhere classified

142

450

2.54

22.73

1.6

1.5

—

Diseases of the skin and subcutaneous tissue

158

310

2.56

22.39

1.7

1.5

—

Other infectious diseases, including avohilmo

6.48

22.17

2.0

1.5

—

Other diseases of pericardium

19.73

22.15

1.3

—

Tramadol

130

288

2.72

21.85

1.6

—

Implicit fungal Sepsis

17.34

21.82

2.0

1.5

—

Non-ischemic cardiomyopathy

192

3.40

21.70

1.6

1.5

—

Adjustment and management of implanted device

104

4.73

21.67

1.3

1.6

—

Other acute lower respiratory infections

110

381

2.75

21.41

1.7

1.5

—

Drug-induced neutropenia

6.60

21.29

1.4

1.6

—

Atrial fibrillation and flutter with reimbursement

4.62

20.76

1.4

1.5

—

Other interstitial pulmonary diseases

114

4.41

20.29

1.6

1.5

—

Interstitial lung disease endpoints

115

4.37

20.07

1.6

1.5

—

Interstitial lung disease

115

4.37

20.07

1.6

1.5

—

Pneumonia due to other infectious organisms, not elsewhere classified

17.59

20.06

1.7

1.3

—

Osteopathies and chondropathies

108

368

2.69

19.89

1.6

—

Asthma-related pneumonia

276

3.04

19.78

1.5

1.6

—

Asthma, hospital admissions 3, pneumonia

276

3.04

19.78

1.5

1.6

—

Asthma-related pneumonia or sepsis

276

3.04

19.78

1.5

1.6

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

25.35

19.64

1.7

1.2

—

Cerebrovascular diseases (FINNGEN)

4.17

19.23

1.6

1.5

—

Persons encountering health services in other circumstances, wide

181

420

2.22

19.15

1.6

1.5

—

Malignant neoplasm of bladder, including Hilmo

5.92

19.12

1.4

—

COPD (mode)

4.57

18.82

1.7

1.3

—

Respiratory tuberculosis, confirmed

24.43

18.74

1.7

1.2

—

Respiratory tuberculosis, confirmed, including avohilmo

24.41

18.74

1.7

1.2

—

ILD, hospital admissions

113

4.27

18.72

1.6

1.5

—

Viral pneumonia (unknown virus, not influenza)

7.35

18.65

1.7

1.5

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

5.64

18.41

1.9

1.2

—

Acute bronchitis

288

2.90

18.39

1.6

1.5

—

Glomerular disorders in diseases classified elsewhere

4.79

17.97

1.8

1.5

—

Conduction disorders

147

3.50

17.82

1.3

1.5

—

Cardiovascular diseases (excluding rheumatic etc)

127

3.38

17.81

1.6

1.7

—

Dyspnoea

151

489

2.23

17.78

1.7

1.5

—

Abnormalities of breathing

135

321

2.41

17.74

1.7

1.5

—

Any reimbursement code in KELA

4.04

17.64

1.7

—

Rheumatoid arthritis

189

3.24

17.59

1.6

1.7

—

Other and unspecified dermatitis

375

2.62

17.56

1.8

1.5

—

Protozoal diseases

13.36

17.50

2.0

1.3

—

Osteoporosis

162

3.47

17.46

1.5

—

Pneumocystosis

19.23

17.43

1.8

1.3

—

Pneumocystosis, including avohilmo

19.23

17.43

1.8

1.3

—

Myelodysplastic syndrome

43.66

17.41

2.2

1.2

—

Other diseases of intestines

159

399

2.22

17.36

1.6

—

Protozoal diseases, including avohilmo

12.79

17.18

2.0

1.4

—

Infections of the skin and subcutaneous tissue

110

442

2.45

17.16

1.8

1.6

—

Explicit bacterial Sepsis

5.77

17.09

1.3

1.7

—

Explicit bacterial Sepsis, including avohilmo

5.77

17.09

1.3

1.7

—

Dermatitis

112

452

2.43

17.06

1.8

1.5

—

Seropositive rheumatoid arthritis

152

3.61

17.06

1.6

1.7

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

+∞

17.04

2.2

0.0

—

Abnormal findings on examination of blood, without diagnosis

104

373

2.53

17.00

1.7

1.5

—

Other disorders of skin and subcutaneous tissue

129

475

2.29

16.83

1.7

1.5

—

Chronic lymphocytic leukaemia, helper endpoint

15.32

16.70

1.9

1.1

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

15.32

16.70

1.9

1.1

—

Chronic lymphocytic leukaemia

15.32

16.70

1.9

1.1

—

Endocarditis

15.25

16.68

1.3

1.4

—

Methotrexate

5.79

16.62

1.6

1.3

—

Cardiodefibrillation

311

2.73

16.57

1.3

1.6

—

Haemophagocytic lymphohistiocytosis

+∞

16.53

2.3

0.0

—

L01XX Other antineoplastic agents

6.15

16.39

1.7

1.3

—

Pacemaker

285

2.75

16.28

1.3

1.6

—

Other viral diseases, not elsewhere classified, including avohilmo

143

3.62

16.24

1.3

1.5

—

Other and unspecified iron deficiency

240

2.96

16.05

1.7

1.6

—

Acute upper respiratory infections of multiple and unspecified sites

122

382

2.33

16.01

1.6

1.5

—

Presence of other functional implants

104

282

2.53

15.94

1.5

—

Diseases of arteries, arterioles and capillaries

129

418

2.27

15.88

1.4

1.6

—

Hard cardiovascular diseases

138

363

2.25

15.80

1.6

—

Opioids

132

293

2.33

15.73

1.7

1.5

—

Medical observation and evaluation for suspected diseases and conditions

106

209

2.60

15.69

1.8

1.3

—

Heart failure and bmi 25plus

192

2.86

15.67

1.6

1.5

—

ILD, hospital admissions 1, main diag only

103

4.10

15.58

1.5

1.4

—

Gout

197

3.01

15.53

1.4

1.6

—

Pain, not elsewhere classified

108

3.99

15.43

2.0

1.4

—

Intestinal infectious diseases

147

519

2.11

15.23

1.7

1.5

—

Cardiovascular diseases

108

3.29

14.97

1.6

1.7

—

Aspergillosis, including avohilmo

33.42

14.97

2.8

1.5

—

Symptoms and signs involving the urinary system

130

448

2.19

14.90

1.6

1.5

—

Finngen Rheumatological endpoints

134

342

2.23

14.86

1.6

—

Hypothyroidism (congenital or acquired)

7.07

14.81

1.9

1.6

—

Other respiratory disorders and diseases

154

3.39

14.73

1.7

1.6

—

Other diseases of the respiratory system

154

3.39

14.73

1.7

1.6

—

Rare circulating lymphoid malignancy, including Hilmo

18.65

14.71

1.7

1.3

—

Dermatitis and eczema

170

502

2.01

14.69

1.7

1.5

—

Other systemic involvement of connective tissue (FG)

152

3.37

14.53

1.6

1.7

—

Factors influencing health status and contact with health services

4.80

14.51

1.7

1.4

—

Streptococcal septicaemia

11.37

14.25

1.3

1.8

—

Streptococcal septicaemia, including avohilmo

11.37

14.25

1.3

1.8

—

Thoracic aortic aneurysm

124

3.65

14.23

1.3

1.7

—

Gout, FINNGEN

245

2.81

14.19

1.4

1.5

—

Miliary tuberculosis

+∞

14.06

1.9

0.0

—

Aspergillosis

31.61

14.03

1.9

1.5

—

Rheumatoid arthritis, including avohilmo

271

2.70

14.00

1.6

—

Codeine

122

291

2.27

13.96

1.6

1.5

—

Hypothyroidism, levothyroxine purchases

6.83

13.95

1.9

1.6

—

Hypothyroidism and >3 levothyroxin purchases

6.83

13.95

1.9

1.6

—

Asthma-related infections

101

427

2.31

13.86

1.5

1.6

—

Asthma, hospital admission 2, infections

101

427

2.31

13.86

1.5

1.6

—

Atypical mycobacterium lung infection

35.23

13.59

2.6

1.4

—

Other and unspecified disorders of white blood cells

11.02

13.52

1.6

1.3

—

Sulfasalazine

138

3.41

13.51

1.9

1.4

—

Heart failure and coronary heart disease

263

2.45

13.43

1.6

1.5

—

Ischemic heart diseases

135

381

2.11

13.40

1.6

—

Other viral diseases, not elsewhere classified

110

3.73

13.40

1.3

1.5

—

Oedema, not elsewhere classified

140

3.35

13.36

1.7

1.4

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

158

419

2.00

13.31

1.5

1.6

—

4.57

13.27

2.0

1.5

—

Candidiasis

4.02

13.05

1.9

1.5

—

L01XE Protein kinase inhibitors

6.17

12.94

1.5

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

178

3.04

12.89

1.6

—

Metabolic disorders

143

426

2.01

12.64

1.7

1.5

—

Acute upper respiratory infections

153

467

1.96

12.61

1.7

1.5

—

Tuberculosis of other organs

20.42

12.49

2.2

1.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

109

3.18

12.47

1.6

1.5

—

Seropositive rheumatoid arthritis, wide

187

2.95

12.46

1.6

—

Bleeding

136

474

2.01

12.44

1.6

1.5

—

Presence of cardiac and vascular implants and grafts

239

2.50

12.44

1.4

1.5

—

Acute sinusitis

292

2.46

12.38

1.7

1.5

—

Multiple myeloma and malignant plasma cell neoplasms

5.85

12.27

1.5

1.4

—

Intestinal infectious diseases, including avohilmo, including avohilmo

166

487

1.90

12.21

1.6

1.5

—

Other/unspecified seropositive rheumatoid arthritis

184

2.94

12.19

1.6

—

Venous thromboembolism

415

2.23

12.18

1.6

1.5

—

Diagnoses used for exclusion with ILD

195

2.88

12.16

1.6

—

Symptoms and signs involving the circulatory and respiratory systems

133

321

2.08

12.16

1.7

1.5

—

L04AC Interleukin inhibitors

6.04

12.12

1.6

2.1

—

Coronary revascularization (ANGIO or CABG)

128

377

2.06

12.11

1.6

—

Viral infections characterized by skin and mucous membrane lesions

322

2.42

12.07

1.5

1.6

—

Sequelae of external causes of morbidity and mortality

196

2.87

12.05

1.9

1.6

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

136

537

1.97

12.04

1.5

1.6

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

177

2.67

12.03

1.5

—

Undetermined asthma, excluding more controls

9.25

11.94

1.3

—

Percutaneous Coronary Intervention

127

377

2.05

11.83

1.6

—

Examination and observation for other reasons

209

2.40

11.80

1.9

1.3

—

Other specified/unspecified arthritis

177

2.94

11.77

1.7

—

Tuberculosis of other organs, strict

16.66

11.69

2.2

1.3

—

Unspecified haematuria

291

2.35

11.69

1.5

—

Hodgkin lymphoma, hilmo

12.70

11.65

1.5

—

Syncope and collapse

172

2.82

11.65

1.5

1.4

—

Other arthritis (FG)

189

2.86

11.63

1.7

1.6

—

All influenza (not pneumonia)

4.59

11.62

2.3

1.3

—

Diverticular disease of intestine

116

344

2.10

11.59

1.5

1.6

—

Major coronary heart disease event

135

406

1.99

11.58

1.6

—

Persons encountering health services in other circumstances

260

2.55

11.56

1.5

1.6

—

Other systemic involvement of connective tissue

185

2.87

11.48

1.5

1.6

—

Other pleural conditions

4.29

11.46

2.1

1.3

—

Later onset COPD, excluding more controls

4.21

11.39

1.5

1.4

—

Headache

199

2.60

11.38

1.3

1.5

—

Tuberculosis of other organs, strict, including avohilmo

15.26

11.33

2.2

1.3

—

Bronchiectasis

5.14

11.25

1.5

1.3

—

Undetermined asthma

8.29

11.25

1.3

1.2

—

Malignant neoplasm of skin, including Hilmo

198

2.51

11.23

1.6

1.5

—

Noninfective enteritis and colitis

339

2.33

11.23

1.8

1.5

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

441

2.15

11.15

1.6

—

Malignant neoplasm of bladder

8.04

11.05

1.4

—

Aortic valve malfunction, age under 60 years

4.27

11.00

1.2

1.8

—

Depression medications

5.66

10.95

1.6

—

Early onset COPD, excluding more controls

4.09

10.82

1.8

1.3

—

Suppurative and necrotic conditions of lower respiratory tract

5.16

10.79

1.5

1.3

—

Zoster [herpes zoster], including avohilmo

376

2.21

10.74

1.5

1.6

—

Spondyloarthritis

104

3.47

10.68

1.5

—

Disorders of other endocrine glands

294

2.38

10.58

1.7

1.5

—

Emergency coronary revascularization (for ACS)

134

420

1.93

10.57

1.6

—

Other disorders involving the immune mechanism, not elsewhere classified

11.33

10.56

2.2

1.5

—

Persons with potential health hazards related to communicable diseases

192

2.74

10.54

1.8

1.6

—

Multiple myeloma, including Hilmo

9.22

10.51

1.5

1.2

—

Symptoms and signs involving the digestive system and abdomen

143

376

1.91

10.44

1.6

1.5

—

Gastrointestinal diseases

124

2.67

10.40

1.8

1.4

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

4.08

10.40

1.2

1.8

—

Diarrhoea and gastroenteritis of presumed infectious origin

101

439

2.06

10.36

1.8

1.5

—

Pulmonary heart disease, diseases of pulmonary circulation

254

2.49

10.34

1.6

1.5

—

Unspecified kidney failure

4.17

10.34

1.4

—

Cellulitis

158

2.92

10.30

1.9

1.6

—

Other reaction to severe stress, and adjustment disorders

197

2.69

10.23

2.0

1.4

—

Other disorders of fluid, electrolyte and acid-base balance

245

2.46

10.20

1.8

1.5

—

Haemorrhage from respiratory passages

229

2.48

10.19

1.6

1.4

—

Unspecified acute lower respiratory infection

3.48

10.14

1.6

—

Insulin medication

102

415

2.04

10.13

1.6

1.5

—

Pulmonary embolism

227

2.56

10.13

1.6

1.5

—

Pericarditis

11.37

10.06

1.3

—

Secondary hypertension

7.78

9.97

1.8

1.6

—

Pulmonary heart disease

229

2.54

9.96

1.6

1.5

—

Disorders of gallbladder, biliary tract and pancreas

144

489

1.83

9.88

1.7

1.5

—

Sarcoidosis

3.49

9.87

1.7

1.5

—

Symptoms and signs involving the skin and subcutaneous tissue

109

527

1.95

9.84

1.7

1.5

—

Malignant neoplasm of skin

189

2.44

9.84

1.6

1.5

—

Sequelae with surgical and medical care as external cause

157

2.88

9.82

1.7

1.6

—

Dissection of aorta

8.81

9.79

1.2

1.5

—

Other arrhythmias

268

2.23

9.74

1.7

1.6

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

3.45

9.72

1.6

1.4

—

Hypertensive diseases (excluding secondary)

116

2.76

9.69

1.5

1.6

—

Pain in throat and chest

109

321

2.01

9.68

1.6

1.5

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

172

2.49

9.53

1.5

—

Immunodeficiency with predominantly antibody defects

15.19

9.53

2.0

1.4

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

+∞

9.51

4.9

0.0

—

Exposure to unspecified factor

142

536

1.80

9.43

1.5

1.6

—

Paroxysmal tachycardia

3.35

9.40

1.7

1.5

—

Insulin, combination of fast acting with intermediate-acting or long-acting

102

470

1.97

9.38

1.6

1.5

—

Giant cell arteritis

8.08

9.34

1.4

1.5

—

Kidney transplant status

7.30

9.21

2.0

1.8

—

Cough

250

2.35

9.13

1.4

1.5

—

Aortic aneurysm

205

2.54

9.12

1.5

1.6

—

Parasetamol

212

2.15

9.09

1.7

1.5

—

Immunodeficiencies

8.33

9.06

1.8

1.5

—

Basal cell carcinoma, including Hilmo

172

2.44

9.05

1.5

—

Other (seronegative) rheumatoid arthritis, wide

137

2.93

9.05

1.6

1.5

—

Iron deficiency anaemia secondary to blood loss (chronic)

116

3.11

9.04

1.3

1.6

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

10.13

9.03

2.3

1.5

—

Polymyalgia rheumatica

3.42

9.02

1.4

1.5

—

Diseases of oesophagus, stomach and duodenum

145

482

1.78

8.94

1.9

1.5

—

Non-allergic asthma (mode), excluding more controls

4.53

8.92

1.3

1.4

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

7.98

8.85

1.6

1.2

—

Candidiasis, including avohilmo

201

2.54

8.84

1.9

1.5

—

Drug-induced osteoporosis with pathological fracture

16.57

8.58

1.2

1.3

—

Human immunodeficiency virus [HIV] disease

16.52

8.57

4.0

1.5

—

Human immunodeficiency virus [HIV] disease, including avohilmo

16.52

8.57

4.0

1.5

—

Other skin changes

147

2.80

8.56

1.7

1.5

—

Polyarteritis nodosa and related conditions

20.41

8.50

1.3

—

Chronic lower respiratory diseases

158

485

1.72

8.46

1.6

—

Codeine or tramadol medication

151

473

1.73

8.45

1.5

1.6

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

+∞

8.45

5.1

0.0

—

Other functional intestinal disorders

281

2.20

8.42

1.3

1.6

—

Other disorders of urethra and urinary system

351

1.94

8.30

1.6

1.5

—

Non-allergic asthma (mode)

4.25

8.27

1.3

1.4

—

Non-invasive ventilation

3.06

8.26

1.5

1.4

—

Other disorders of kidney and ureter

3.21

8.19

2.0

1.5

—

Gout, idiopatic and unspecified

221

2.40

8.19

1.4

1.6

—

Low back pain

106

380

1.88

8.15

1.7

1.6

—

Drug-induced cataract

11.83

8.09

2.2

1.4

—

Leukaemia of unspecified cell type

22.63

8.06

1.8

1.6

—

Inflammatory diseases of the central nervous system

4.02

8.06

2.0

1.7

—

General examination and investigation of persons without complaint and reported diagnosis

209

2.09

8.04

1.6

1.3

—

Zoster [herpes zoster]

141

2.77

8.03

1.6

1.5

—

DVT of lower extremities and pulmonary embolism

337

2.10

7.97

1.6

—

Abdominal and pelvic pain

133

376

1.78

7.95

1.6

1.5

—

Pain in limb

118

414

1.81

7.95

1.6

1.5

—

Biological medication for rheuma

3.14

7.93

1.5

1.7

—

304

2.16

7.92

1.5

1.6

—

Other noninfective gastroenteritis and colitis

165

2.61

7.89

1.8

1.5

—

Cutaneous abscess, furuncle and carbuncle

171

2.58

7.89

2.1

1.6

—

Mycoses, including avohilmo

125

544

1.75

7.79

1.8

1.5

—

Mature T/NK-cell lymphomas, hilmo

15.32

7.75

2.6

1.4

—

Marginal zone B-cell lymphoma, including Hilmo

15.26

7.74

2.2

1.3

—

Glomerulonephritis

3.65

7.72

1.8

1.6

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

132

489

1.73

7.68

1.7

1.5

—

Nonischemic cardiomyopathy

3.53

7.67

1.5

1.6

—

5-aminosalicylic acid

3.26

7.63

1.9

1.3

—

Donors of organs and tissues

18.63

7.62

1.6

1.3

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

18.61

7.62

4.5

1.5

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

18.61

7.62

4.5

1.5

—

Iridocyclitis

151

2.65

7.61

1.9

1.5

—

Type 2 diabetes, wide definition

114

399

1.80

7.56

1.8

1.5

—

Diseases of the eye and adnexa

244

1.95

7.56

1.6

—

Polyneuropathies and other disorders of the peripheral nervous system

175

2.52

7.55

2.0

1.5

—

Vocal cord dysfunction

4.41

7.55

1.3

1.5

—

Abnormal findings on diagnostic imaging of other body structures

3.23

7.50

1.5

—

Ulcer of lower limb, not elsewhere classified

108

2.97

7.48

1.7

1.5

—

Myeloproliferative diseases

3.67

7.45

1.8

1.4

—

Malignant neoplasm of breast, HER2-negative

2.78

7.44

1.4

1.5

—

Malignant neoplasm of breast

2.78

7.43

1.4

1.5

—

Symptoms and signs concerning food and fluid intake

4.39

7.39

1.2

1.4

—

SLE (Finngen)

13.43

7.39

1.8

1.4

—

Anaemia in chronic diseases classified elsewhere

8.45

7.33

1.4

—

Gout, unspecified

172

2.51

7.30

1.3

1.6

—

STROKE

261

2.01

7.29

1.5

1.6

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

122

2.79

7.26

1.3

1.5

—

Chronic apical periodontitis

144

482

1.68

7.26

1.5

1.6

—

Respiratory tuberculosis, clinically confirmed

16.02

7.25

2.1

1.1

—

Osteoporosis with pathological fracture (FG)

5.79

7.21

1.5

—

Diseases of liver

287

2.13

7.14

1.7

1.6

—

Seronegative rheumatoid arthritis

3.44

7.10

1.7

1.6

—

Other disorders of ear

127

481

1.71

7.07

1.5

1.6

—

8.86

7.06

2.1

1.3

—

Spondylopathies

110

364

1.79

7.04

1.6

—

Diabetes mellitus

126

424

1.72

6.99

1.7

1.5

—

Decubitus ulcer and pressure area

4.38

6.96

1.5

1.3

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

2.67

6.94

1.4

1.6

—

Malignant neoplasm of breast, including Hilmo

2.67

6.94

1.4

1.6

—

Other soft tissue disorders, not elsewhere classified

125

415

1.71

6.88

1.6

1.5

—

Constipation

125

501

1.69

6.81

1.4

1.6

—

Basal cell carcinoma

167

2.25

6.81

1.5

—

Asthma (diagnoses ohter than nonallergic)

116

548

1.71

6.81

1.4

1.6

—

Drug-induced osteoporosis

16.97

6.77

1.4

1.2

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

5.68

6.76

2.2

1.5

—

Acute and subacute iridocyclitis

126

2.70

6.74

2.1

1.6

—

Viral pneumonia (known virus, not influenza)

7.22

6.71

1.3

1.4

—

Other diseases of urinary system

131

438

1.68

6.70

1.6

—

Other and unspecified polyneuropathies, also in other diseases

157

2.49

6.57

2.1

1.6

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

157

2.49

6.57

1.5

1.6

—

Discitis, unspecified

10.16

6.55

1.3

1.6

—

Hydronephrosis

3.45

6.55

2.0

1.4

—

Invasive ventilation

3.82

6.53

1.7

1.5

—

Malignant neoplasm of digestive organs, including Hilmo

181

2.20

6.46

1.3

1.5

—

Disorders of mineral metabolism

3.51

6.43

1.5

1.6

—

Noninfectious colitis NAS

2.98

6.37

1.7

1.5

—

Other special examinations and investigations of persons without complaint or reported diagnosis

209

1.94

6.35

1.6

1.3

—

Systemic lupus erythematosus

9.30

6.29

1.8

1.7

—

Urinary track infection

126

2.23

6.28

1.6

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

130

502

1.64

6.23

1.6

1.5

—

Other specific joint derangements/joint disorders

313

1.81

6.22

1.4

1.6

—

Diabetes, varying definitions

122

425

1.66

6.13

1.8

1.5

—

Insulin, fast-acting

272

2.06

6.09

1.6

—

Hyperkalaemia

3.77

6.08

1.4

1.3

—

Conductive and sensorineural hearing loss

114

451

1.68

6.08

1.5

1.6

—

Neurological diseases

102

291

1.76

6.04

1.5

1.6

—

Anterior Iridocyclitis

134

2.54

6.01

2.1

1.5

—

Type 2 diabetes

120

418

1.66

6.00

1.7

1.5

—

Hypertension, essential

303

1.77

5.93

1.4

1.6

—

Fracture of lumbar spine and pelvis

165

2.36

5.90

1.5

1.6

—

Persons encountering health services for examination and investigation

209

1.90

5.90

1.7

1.3

—

Gingivitis and periodontal diseases

126

396

1.64

5.90

1.6

—

Chronic ulcer of skin, not elsewhere classified

4.02

5.89

1.4

1.3

—

Dental operations

215

1.89

5.89

1.7

1.6

—

Endocrine, nutritional and metabolic diseases

236

1.84

5.88

1.6

1.4

—

Disorders of lens

354

1.74

5.88

1.6

—

Malignant neoplasm, without specification of site, including Hilmo

6.39

5.85

1.4

1.1

—

Acquired haemolytic anaemia

9.26

5.79

1.5

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.75

5.72

1.4

1.6

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

5.58

5.67

1.7

1.4

—

Gout, strict definition

157

2.36

5.62

1.4

1.6

—

Cerebrovascular diseases

110

462

1.65

5.61

1.5

—

Malignant immunoproliferative diseases

13.13

5.61

2.1

1.4

—

Diseases of the ear and mastoid process

138

436

1.59

5.60

1.7

1.6

—

Secondary thrombocytopenia

13.07

5.60

1.8

1.4

—

SLE, strict definition

8.52

5.56

1.8

1.7

—

SLE, ICD10

8.52

5.56

1.8

1.7

—

Infection of intervertebral disc (pyogenic)

10.17

5.55

1.9

1.4

—

Seropositive rheumatoid arthritis, strict definition

2.73

5.51

1.9

1.6

—

Nausea and vomiting

161

2.30

5.45

1.6

—

Lung transplant status

16.40

5.44

2.6

1.2

—

Lung transplantation

16.40

5.44

2.6

1.2

—

Other and unspecified disorders of skin and subcutaneous tissue

4.87

5.42

1.8

1.3

—

Gonarthrosis [arthrosis of knee](FG)

305

1.74

5.42

1.4

1.6

—

Pain in joint

255

1.83

5.41

1.5

1.6

—

Chronic rhinitis, nasopharyngitis and pharyngitis

211

2.13

5.41

1.4

1.6

—

Abnormalities of heart beat

217

2.10

5.40

1.7

1.5

—

Haemolytic anaemias

6.24

5.39

1.9

1.4

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

7.92

5.35

1.7

1.2

—

Multiple myeloma

7.92

5.35

1.7

1.2

—

Other/unspecified rheumatoid arthritis

2.87

5.34

1.6

1.5

—

Lung cancer and mesothelioma

3.27

5.31

1.6

1.4

—

Sensorineural hearing loss

108

440

1.64

5.30

1.5

1.6

—

Tuberculosis of nervous system

+∞

5.28

2.0

0.0

—

Tuberculosis of nervous system, including avohilmo

+∞

5.28

2.0

0.0

—

Inflammatory bowel disease

220

2.09

5.27

1.8

1.5

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

6.75

5.26

1.1

1.5

—

Hypertensive diseases

310

1.71

5.25

1.4

1.6

—

Hypertension

310

1.71

5.25

1.4

1.6

—

Fluid overload

+∞

5.24

1.2

0.0

—

Hypersplenism

+∞

5.23

1.0

0.0

—

Other dialysis

5.96

5.23

2.1

1.5

—

Temporal arteritis

5.95

5.22

1.5

1.4

—

Dermatitis due to substances taken internally

5.93

5.22

2.8

1.7

—

Visual disturbances

367

1.83

5.21

1.5

1.6

—

Cholelithiasis, broad definition with cholecystitis

111

457

1.62

5.20

1.8

1.5

—

Viral infections of the central nervous system, including avohilmo

3.65

5.20

2.1

1.7

—

Abnormal results of function studies

3.65

5.20

1.4

1.8

—

Antihypertensive medication - note that there are other indications

144

2.03

5.17

1.8

1.7

—

Pneumothorax

4.59

5.17

1.8

1.3

—

Other diseases of biliary tract

3.23

5.16

1.2

1.4

—

Disorders of thyroid, IBD co-morbidities

3.76

5.15

1.4

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

121

2.49

5.11

1.7

—

Other and unspecified immunodeficiencies with predominantly antibody defects

13.53

5.09

1.5

1.3

—

Other abnormalities of plasma proteins

13.49

5.09

1.5

—

Diseases of spleen

8.43

5.07

2.1

1.3

—

Other joint disorders

102

320

1.66

5.07

1.4

1.6

—

Insulin, fast-acting or short human

292

1.92

5.06

1.6

—

Diseases of oral cavity, salivary glands and jaws

205

1.84

5.05

1.6

—

Disorders of optic nerve and visual pathways

3.41

5.02

1.2

1.8

—

Follicular lymphoma, hilmo

4.72

4.99

1.3

1.6

—

Lichen simplex chronicus and prurigo

4.71

4.98

1.7

1.6

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

107

2.55

4.98

1.4

1.6

—

Viral infections of the central nervous system

3.67

4.92

2.1

1.6

—

Disorders resulting from impaired renal tubular function

5.46

4.91

1.2

1.4

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

122

524

1.56

4.90

1.5

—

Exclusions for E4_PCOS_BROAD

112

2.50

4.85

2.1

1.6

—

Use of hypnotics and sedatives

132

492

1.53

4.83

1.5

1.6

—

External causes of morbidity and mortality

213

1.79

4.83

1.6

1.5

—

Meniscus derangement

283

1.76

4.82

1.4

1.6

—

Diseases of pulp and periapical tissues and dental caries

249

1.73

4.82

1.7

1.6

—

Gastroduodenal ulcer

214

2.05

4.81

1.6

1.5

—

Hypo-osmolality and hyponatraemia

136

2.34

4.80

2.2

1.5

—

Other renal tubulo-interstitial diseases

11.51

4.79

1.8

1.4

—

Periodontitis

125

517

1.54

4.79

1.7

1.5

—

Malignant neoplasm of brain, including Hilmo

6.50

4.77

1.8

1.2

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

399

1.74

4.77

1.4

1.6

—

Idiopathic gout

2.75

4.77

1.4

—

Cirrhosis of liver, NAS

3.59

4.76

1.8

1.5

—

Other diseases of arteries and capillaries

3.17

4.76

1.2

1.4

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

398

1.68

4.75

1.6

1.5

—

Benign neoplasms

120

418

1.56

4.73

1.6

1.5

—

Disorders of sclera, cornea, iris and ciliary body

424

1.72

4.70

1.6

—

COPD, hospital admission 2, with asthma infections

232

1.93

4.70

1.8

1.6

—

Genitourinary diseases

186

1.83

4.69

1.5

1.6

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

3.04

4.69

1.4

—

Malignant neoplasm of digestive organs

168

2.05

4.68

1.4

1.5

—

Asthma and opportunity respiratory infection

4.69

4.68

2.0

1.3

—

Other metabolic disorders

2.84

4.64

1.5

1.4

—

Giant cell arteritis with polymyalgia rheumatica

5.04

4.63

1.5

1.3

—

Spondylosis

341

1.72

4.61

1.6

—

Dorsalgia

114

384

1.57

4.61

1.6

1.5

—

Neurological diseases, wide definition

2.86

4.61

1.8

1.3

—

Crohn disease

2.76

4.60

1.9

1.6

—

Adrenocortical insufficiency

5.49

4.60

2.3

1.4

—

Protein-energy malnutrition of moderate and mild degree

14.24

4.59

1.4

—

Chronic periodontitis, including avohilmo

124

518

1.53

4.58

1.7

1.5

—

Injury, poisoning and certain other consequences of external causes

173

1.86

4.58

1.7

1.4

—

Disorders of parathyroid gland

145

2.25

4.56

1.4

1.5

—

Calcific aortic valvular stenosis, operated

244

1.94

4.55

1.3

1.6

—

Calcific aortic valvular stenosis

244

1.94

4.55

1.3

1.6

—

Herpesviral [herpes simplex] infections

2.81

4.54

1.7

1.6

—

In situ neoplasms

304

1.84

4.53

1.9

1.5

—

Visual disturbances and blindness

406

1.72

4.53

1.5

1.6

—

Other cataract

265

1.80

4.53

1.7

1.6

—

Convulsions, not elsewhere classified

2.61

4.52

1.4

—

Follow-up examination after treatment for malignant neoplasms

3.06

4.51

1.3

—

Malignant neoplasm of eye, brain and central nervous system

6.70

4.47

1.1

1.2

—

Chronic nephritic syndrome

5.25

4.46

1.8

1.4

—

Encephalitis

5.83

4.44

2.1

1.4

—

Generalized skin eruption due to drugs and medicaments

5.82

4.44

2.5

1.4

—

Pneumonia due to Streptococcus pneumoniae

5.82

4.44

2.0

1.3

—

Respiratory insufficiency

5.79

4.42

1.9

1.2

—

Insulin, intermediate and long-acting

453

1.66

4.40

1.5

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

216

1.99

4.38

1.5

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

201

1.96

4.38

1.8

1.6

—

Respiratory tuberculosis, not confirmed

4.67

4.37

1.9

1.4

—

Artificial opening status

4.66

4.37

1.5

1.4

—

Abscess of lung

7.59

4.36

1.2

1.3

—

Malnutrition

7.57

4.36

1.3

1.4

—

Gastro-oesophageal reflux disease

460

1.61

4.35

1.7

1.5

—

Type 2 diabetes, definitions combined

110

412

1.55

4.33

1.8

1.5

—

Disorders of calcium metabolism

3.35

4.32

1.5

1.4

—

Disorders of choroid and retina

109

495

1.54

4.30

1.5

1.6

—

Disorders of oesophagus in diseases classified elsewhere

5.56

4.30

1.7

1.4

—

Other encephalitis

6.30

4.30

2.2

1.3

—

Respiratory tuberculosis, not confirmed, including avohilmo

4.51

4.24

1.9

1.4

—

Myeloproliferative diseases (CML excluded)

3.05

4.24

1.8

1.4

—

Diseases of the musculoskeletal system and connective tissue

149

1.89

4.23

1.7

1.5

—

Pruritus

3.04

4.23

1.2

1.5

—

Calcific aortic valvular stenosis, diagnosis (helper)

244

1.90

4.22

1.3

1.6

—

Operations 2 for CAVS

244

1.90

4.22

1.3

1.6

—

Calcific aortic valvular stenosis, including rheumatic fever

244

1.89

4.21

1.3

1.6

—

Type 2 diabetes, definitions combined, including avohilmo

111

417

1.54

4.20

1.7

1.5

—

Other disorders of optic [2nd] nerve and visual pathways

4.13

4.20

1.3

1.6

—

Squamous cell neoplasms and carcinomas of the skin

3.14

4.19

1.4

1.2

—

Diseases of the digestive system

376

1.72

4.17

1.6

—

Care involving use of rehabilitation procedures

353

1.71

4.15

1.7

1.5

—

Type of accident

200

2.00

4.15

1.5

—

Episodal and paroxysmal disorders

126

426

1.50

4.14

1.4

1.6

—

Allergic asthma (mode), excluding more controls

3.25

4.14

1.5

1.7

—

Diabetic nephropathy, excluding more controls

2.40

4.13

1.5

1.6

—

Misadventures to patients during surgical and medical care

2.48

4.12

2.7

1.4

—

Malignant neoplasm of breast, HER-positive

2.37

4.12

1.3

1.6

—

Type 2 diabetes, strict (exclude DM1)

111

422

1.53

4.12

1.8

1.5

—

Other antidepressants

130

446

1.49

4.12

1.5

1.6

—

Malignant neoplasm of breast, ER-positive, including Hilmo

2.37

4.11

1.3

1.6

—

Fentanyl

2.98

4.10

1.4

—

IBD patients in KELA-register

141

2.20

4.10

1.9

1.5

—

Adult respiratory distress syndrome

8.11

4.07

1.9

1.4

—

Malignant neoplasm of brain

8.04

4.06

1.1

1.3

—

Ascites

3.20

4.05

1.3

1.4

—

Psoriasis vulgaris

129

2.25

4.04

1.9

1.6

—

Ulcerative colitis, NAS

2.56

4.04

2.3

1.5

—

Other and unspecified psoriasis

3.34

4.04

1.3

1.7

—

Inflammatory bowel disease, strict (require KELA)

142

2.19

4.03

1.9

1.5

—

Respiratory disorders in diseases classified elsewhere

10.11

4.02

2.0

1.4

—

Fibrosis and cirrhosis of liver

2.94

4.00

1.9

1.7

—

Acute generalized exanthematous pustulosis

5.02

4.00

2.5

1.5

—

Preparatory care for dialysis

3.91

3.99

1.3

1.4

—

Carrier of infectious disease

6.48

3.99

2.0

1.4

—

Chronic tubulo-interstitial nephritis

6.46

3.98

2.1

1.3

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

411

1.64

3.98

1.4

1.7

—

Congenital malformations, deformations and chromosomal abnormalities

378

1.68

3.97

1.3

1.7

—

Localized swelling, mass and lump of skin and subcutaneous tissue

239

1.89

3.94

1.8

1.5

—

Dialysis

4.47

3.93

1.3

1.4

—

Other disorders of adrenal gland

4.47

3.93

2.3

1.6

—

Ulcerative colitis

164

2.08

3.90

1.9

1.5

—

Cholecystitis

106

2.36

3.89

1.8

1.5

—

Urticaria and erythema

233

1.89

3.89

1.6

—

Allergic asthma (mode)

3.12

3.88

1.5

1.7

—

Vasculitis limited to skin, not elsewhere classified

7.32

3.86

1.3

—

Psychiatric diseases

121

407

1.49

3.86

1.6

1.5

—

Chronic sinusitis

306

1.76

3.84

1.8

1.6

—

COPD

313

1.69

3.83

1.7

1.6

—

Other diseases of upper respiratory tract

132

472

1.46

3.82

1.4

1.6

—

Retention of urine

234

1.80

3.81

1.5

1.6

—

Congenital malformations of heart and great arteries

2.55

3.81

1.3

1.7

—

Malignant neoplasm of urinary organs, including Hilmo

3.07

3.80

1.5

1.3

—

Diseases of external ear

271

1.81

3.80

2.0

1.6

—

Chronic gastritis

208

1.93

3.75

1.9

1.6

—

Phlebitis and thrombophlebitis (not including DVT)

160

2.07

3.75

1.6

1.5

—

Sleep apnoea

116

495

1.48

3.74

1.5

1.6

—

324

1.69

3.72

1.8

1.5

—

Other chronic obstructive pulmonary disease

300

1.69

3.71

1.6

—

Other CVD (FINNGEN)

2.81

3.69

1.3

1.5

—

Persons encountering health services for specific procedures, not carried out

3.60

3.69

1.5

1.8

—

Chorioretinal inflammation

5.03

3.69

2.0

1.4

—

Cardiomyopathy, other and unspecified

3.83

3.69

1.5

1.7

—

Systemic lupus erythematosus, unspecified

6.70

3.67

1.9

1.7

—

Lung diseases due to external agents

109

2.30

3.67

1.4

1.5

—

Sleep disorders (combined)

130

469

1.45

3.66

1.4

1.6

—

Congenital malformations of the circulatory system

2.38

3.63

1.3

1.7

—

Mucosal proctocolitis

2.54

3.62

1.9

1.5

—

Other embolism and thrombosis

2.48

3.62

1.7

1.5

—

Crohn's disease of large intestine

4.42

3.62

1.7

1.8

—

Cholelithiasis

100

453

1.51

3.61

1.7

1.5

—

Follow-up examination after treatment for conditions other than malignant neoplasms

175

1.83

3.59

1.6

1.4

—

Hyperlipidaemia, other/unspecified

314

1.69

3.58

1.5

—

Lower back pain or/and sciatica

126

544

1.44

3.57

1.7

1.5

—

Chronic myeloproliferative disease

7.87

3.57

2.3

1.4

—

Other and unspecified vasculitis limited to skin

7.83

3.56

1.3

—

Psoriasis (vulgaris), strict definition

4.79

3.55

2.9

1.8

—

Paralytic ileus and intestinal obstruction

191

1.94

3.55

1.8

1.6

—

Stroke, excluding SAH

396

1.55

3.53

1.4

1.6

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

2.81

3.52

1.6

—

Polycystic kidney disease

5.33

3.51

1.3

1.5

—

Idiopathic thrombocytopenic purpura

5.33

3.51

1.8

1.4

—

Ulcerative enterocolitis

5.32

3.51

2.3

1.4

—

Sequelae of tuberculosis

6.21

3.50

2.5

1.2

—

Sequelae of tuberculosis, including avohilmo

6.20

3.50

2.5

1.2

—

Acute bronchiolitis

5.43

3.50

1.6

1.3

—

Mantle cell lymphoma, including Hilmo

10.09

3.50

1.2

—

Acute lymphadenitis

4.24

3.50

2.5

1.5

—

Pyothorax

3.63

3.49

1.8

1.4

—

Crohn's disease NAS

3.62

3.49

1.7

—

Peripheral artery operations in Hilmo

2.37

3.47

1.2

1.6

—

Volume depletion

2.61

3.46

1.2

1.4

—

Asthma, hospital admissions , main diagnosis only

553

1.49

3.45

1.4

1.6

—

Gonarthrosis

282

1.58

3.44

1.4

1.6

—

Contact with and exposure to communicable diseases

138

2.09

3.43

1.2

1.5

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

104

416

1.48

3.42

1.8

1.5

—

Other complications of surgical and medical care, not elsewhere classified

2.76

3.41

2.2

1.5

—

Hepatic failure, not elsewhere classified

4.10

3.39

1.5

1.4

—

Psoriasis

216

1.85

3.38

1.8

1.6

—

Senile cataract

330

1.55

3.38

1.5

1.6

—

Viral warts, including avohilmo

133

2.11

3.38

1.4

1.6

—

Other and unspecified diseases of blood and blood-forming organs

5.03

3.37

1.3

—

Hypoparathyroidism

5.02

3.37

1.3

1.4

—

Osteomyelitis

3.11

3.37

1.2

1.4

—

Adalimumab

2.84

3.35

1.5

1.8

—

Unspecified nephritic syndrome

5.76

3.34

2.3

1.4

—

Other diseases of hard tissues of teeth

203

1.66

3.34

1.6

—

Other disorders of lacrimal gland

276

1.74

3.32

1.9

1.5

—

Dorsopathies

112

389

1.46

3.29

1.5

—

Intracranial trauma

244

1.66

3.29

1.4

1.6

—

Infectious mononucleosis, including avohilmo

3.94

3.28

1.8

1.7

—

Infectious mononucleosis

3.94

3.28

1.8

1.7

—

Other arthrosis

273

1.62

3.28

1.3

1.6

—

Cardiomyopathy

102

2.26

3.27

1.4

1.6

—

Recurrent aphthous stomatitis , including avohilmo

2.30

3.25

1.7

1.5

—

Osteonecrosis

3.03

3.25

1.9

1.4

—

Viral warts

2.67

3.22

1.5

1.8

—

Other chronic obstructive pulmonary disease, including avohilmo

404

1.55

3.22

1.6

1.5

—

Other inflammatory liver diseases

3.34

3.22

1.8

1.5

—

Weight loss

2.51

3.20

1.2

1.4

—

Respiratory conditions due to other external agents

5.38

3.19

1.3

1.5

—

Other or ill-defined heart diseases

4.18

3.19

1.3

1.8

—

Ulcer of oesophagus

2.87

3.19

1.4

1.5

—

Left ventricular outflow tract obstruction, narrow definition

3.81

3.18

1.4

1.6

—

Asthma/COPD (KELA code 203)

105

484

1.45

3.18

1.5

1.6

—

Congenital malformations of cardiac septa

3.81

3.17

1.3

1.6

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

100

2.14

3.16

1.7

1.5

—

Other dorsopathies, not elsewhere classified

108

386

1.45

3.16

1.6

1.5

—

Intestinal adhesions without obstruction

2.73

3.15

2.3

1.5

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

2.96

3.13

1.5

1.4

—

Other diseases of pancreas

2.63

3.13

1.3

1.6

—

Collagenous colitis

2.54

3.12

1.5

1.4

—

Cystic kidney disease

4.52

3.11

1.3

1.4

—

Coronary atherosclerosis

345

1.52

3.11

1.6

1.5

—

Any mental disorder

127

452

1.41

3.11

1.7

1.5

—

Cardiac arrest

3.52

3.11

1.4

1.6

—

Colorectal cancer, including Hilmo

128

2.04

3.10

1.2

1.5

—

Other specified and unspecified retinal disorders

4.02

3.08

2.9

1.4

—

Artificial joint operation, meniscal resection

113

508

1.42

3.08

1.5

1.6

—

Congenital malformations of aortic and mitral valves

4.02

3.08

1.3

1.4

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

308

1.67

3.08

1.5

1.6

—

Carcinoma in situ of skin, other sites/unspecified

7.56

3.06

1.7

1.5

—

Drug-induced adrenocortical insufficiency

7.55

3.06

1.8

1.1

—

Other and unspecified drugs and medicaments

2.69

3.05

1.6

1.7

—

Amputation

2.38

3.05

1.3

1.4

—

Malignant neoplasm, without specification of site

5.86

3.02

1.0

1.2

—

Malignant neoplasm of urinary organs

2.89

3.02

1.5

1.4

—

Disorders of eyelid, lacrimal system and orbit

103

526

1.43

3.02

1.7

1.5

—

Diabetes medication

113

465

1.42

3.00

1.8

1.5

—

Fall on same level

128

490

1.39

3.00

1.6

—

Nephrotic syndrome

4.31

2.99

2.4

1.4

—

Acute drug-induced interstitial lung disorder

10.15

2.99

1.2

1.4

—

Kyphosis

10.08

2.98

1.6

1.2

—

Exclusion endpoint for clefts

10.03

2.98

1.0

1.2

—

Other diseases of the digestive system

271

1.70

2.95

1.6

—

Diseases of pulp and periapical tissues, including avohilmo

115

420

1.42

2.95

1.6

1.5

—

Concussion

243

1.66

2.95

1.3

1.6

—

Tumor necrosis factor alpha inhibitors

2.28

2.93

1.4

1.7

—

GI-bleeding

272

1.69

2.92

1.6

—

Septal defects

3.78

2.91

1.3

1.5

—

Pyogenic arthritis

2.70

2.88

1.6

1.5

—

Ulcerative rectosigmoiditis

2.70

2.88

2.1

1.7

—

Other or unspecified ileus, impaction or obstruction

142

1.97

2.88

2.0

1.6

—

Cystic kidney disease, including avohilmo

4.11

2.88

1.3

1.4

—

Abnormal findings on diagnostic imaging of central nervous system

4.10

2.88

1.4

1.5

—

Other specified/unspecified systemic involvement of connective tissue

3.71

2.88

1.5

1.8

—

Malignant neoplasm of tonsil and base of tongue

6.71

2.87

1.8

1.4

—

Viral meningitis

5.40

2.87

2.3

1.4

—

Hypothyroidism, drug reimbursement

3.88

2.84

1.5

1.8

—

Stroke, including SAH

427

1.46

2.83

1.4

1.6

—

Pain (limb, back, neck, head abdominally)

258

1.52

2.81

1.5

1.6

—

Skin changes due to chronic exposure to nonionizing radiation

311

1.60

2.80

1.8

1.5

—

IgA nephropathy (IgA glomerulonephritis)

4.47

2.80

2.6

1.5

—

Autoimmune hepatitis, wide definition

4.46

2.79

1.8

1.5

—

Other disorders of eye and adnexa

2.23

2.79

1.4

1.6

—

Amputation of toe

2.65

2.79

1.2

1.4

—

COPD, hospital admissions

349

1.55

2.78

1.6

—

Dental caries, including avohilmo

298

1.48

2.77

1.7

1.5

—

Other disorders starting during childhood or adolecense, excluding more controls

6.37

2.77

1.3

—

Other Crohn's disease

3.08

2.77

1.3

1.7

—

Subjective visual disturbances

180

1.84

2.76

1.6

1.5

—

Benign neoplasm: Nasopharynx

8.43

2.76

1.0

1.5

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

8.43

2.76

1.4

1.5

—

Arthrosis

298

1.49

2.75

1.3

1.6

—

Malignant neoplasm of anus and anal canal, including Hilmo

8.40

2.75

1.4

1.3

—

Erythema multiforme

5.03

2.73

1.3

1.4

—

Viral meningitis, including avohilmo

5.02

2.73

2.3

1.4

—

Ischaemic Stroke, excluding all haemorrhages

388

1.48

2.72

1.4

1.6

—

Sleep apnoea, including avohilmo

115

502

1.38

2.72

1.5

1.6

—

Atopic dermatitis, strict definition with reimbursement

126

1.98

2.71

1.2

1.5

—

Papilloedema, unspecified

6.03

2.70

1.2

1.3

—

Acute posthaemorrhagic anaemia

4.23

2.68

1.4

—

Other specified/unspecified inflammatory spondylopathies

4.22

2.68

1.8

1.4

—

COPD, early/later onset

351

1.53

2.67

1.6

—

Exclusions for E4_PCOS_CONSORTIUM

258

1.55

2.67

1.6

—

Hyperparathyroidism

124

2.00

2.67

1.5

1.4

—

Dizziness and giddiness

485

1.43

2.61

1.4

1.5

—

Other disorders of veins

292

1.62

2.60

1.4

1.6

—

Peripheral artery disease

313

1.54

2.60

1.3

1.6

—

Diabetic nephropathy

139

1.92

2.60

1.5

1.7

—

Asthma, including avohilmo

131

535

1.35

2.60

1.5

1.6

—

Hypothyroidism, strict autoimmune

290

1.52

2.59

1.9

1.5

—

Delirium, not induced by alcohol and other psychoactive substances

2.15

2.58

1.3

1.5

—

Bicuspidal aortic valve syndrome

3.62

2.57

1.3

1.4

—

Cystitis

369

1.43

2.57

1.4

1.6

—

Other inflammation of eyelid

107

2.06

2.56

2.0

1.6

—

Other and unspecified acquired haemolytic anaemias

7.22

2.55

1.8

1.4

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

7.22

2.55

3.6

1.4

—

Acute epiglottitis

7.19

2.55

2.8

1.4

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

7.18

2.55

1.4

1.3

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

5.48

2.54

1.8

1.4

—

Cholangitis (primary sclerosing, PSC)

2.87

2.54

1.4

—

Malignant neoplasm of kidney, except renal pelvis

2.86

2.54

1.4

—

Other congenital malformations

2.86

2.54

1.5

1.8

—

Duodenal ulcer

2.23

2.53

1.4

1.5

—

Budesonide

2.50

2.52

2.1

1.3

—

Diabetes, insulin treatment (Kela reimbursement)

111

481

1.37

2.51

1.8

1.5

—

Other CVD

157

1.85

2.51

1.3

1.6

—

Hypokalaemia

2.16

2.50

1.6

1.5

—

Fracture of rib(s), sternum and thoracic spine

262

1.64

2.49

1.3

1.6

—

Type 1 diabetes, wide definition, subgroup 1

115

2.00

2.49

1.3

1.4

—

Hernia

105

506

1.38

2.49

1.5

1.6

—

Carcinoma in situ of other and unspecified sites

2.99

2.49

2.0

1.4

—

Chronic pancreatitis

2.11

2.48

1.5

1.6

—

Disorders of lipoprotein metabolism and other lipidaemias

411

1.41

2.48

1.7

1.5

—

Simple and mucopurulent chronic bronchitis

3.47

2.48

1.2

1.4

—

Pain in thoracic spine

2.11

2.48

2.0

1.6

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

2.32

2.48

1.4

—

Disorders of optic nerve, not elsewhere classified

4.40

2.48

1.3

1.4

—

Ischaemic heart disease, wide definition

432

1.40

2.47

1.6

—

Actinic keratosis

309

1.56

2.47

1.8

1.5

—

Other disorders of the musculoskeletal system and connective tissue

109

2.02

2.45

1.4

1.6

—

Atherosclerosis, excluding cerebral and coronary sclerosis

291

1.54

2.45

1.4

1.6

—

Myocardial infarction

297

1.51

2.44

1.6

1.5

—

Elevated blood glucose level

2.55

2.44

1.6

1.5

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.24

2.43

1.5

1.7

—

Missing teeth due to accident, extraction or parodontitis

493

1.43

2.43

1.8

1.5

—

Disease of hard tissues of teeth, NOS

195

1.56

2.43

1.5

1.6

—

Dysphagia

181

1.77

2.42

1.5

1.6

—

Arthropathies

320

1.42

2.42

1.6

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

2.90

2.41

1.8

—

Carcinoma in situ of skin of other and unspecified parts of face

2.29

2.41

2.1

1.3

—

Crystal arthropathies, rheuma endpoint

5.03

2.40

1.7

1.4

—

Erythema nodosum

5.02

2.40

2.2

1.3

—

Myocarditis

5.01

2.40

1.8

2.0

—

Carcinoma in situ of skin of trunk

3.35

2.39

2.1

1.4

—

Other and unspecified coagulation defects

3.34

2.39

1.2

1.5

—

Non-selective monoamine reuptake inhibitors

269

1.61

2.39

1.4

1.6

—

Other disorders starting during childhood or adolescence

4.96

2.38

1.3

1.2

—

Acquired absence of limb

6.31

2.38

1.8

1.4

—

Eosinophilia

6.29

2.37

1.6

1.1

—

Ulcer of vagina/vulva

6.27

2.37

1.4

1.6

—

Benign neoplasm of mouth and pharynx

2.21

2.37

1.4

1.6

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

6.25

2.37

1.0

1.5

—

Visual field defects

2.42

2.36

1.1

1.4

—

Golimumab

4.13

2.36

1.7

1.5

—

Ovarian dysfunction

4.12

2.36

1.3

2.3

—

Oesophagitis

3.04

2.35

3.0

1.4

—

Congenital malformations of the urinary system

3.04

2.35

1.4

1.6

—

Thyroiditis, ILD-related definition

2.50

2.35

1.3

1.5

—

Etanercept

3.04

2.35

1.6

1.8

—

Other diseases of intestine

111

1.98

2.35

1.6

1.7

—

Need for other prophylactic measures

2.83

2.34

1.4

1.5

—

Other ulcerative colitis

2.83

2.34

1.6

1.7

—

COPD related to multimorbidity

312

1.52

2.30

1.6

1.5

—

Crohn disease (strict definition, require KELA, min 2 HDR)

2.95

2.28

1.9

—

Crohn disease (strict definition, require KELA)

2.95

2.28

1.9

—

Other coagulation defects

2.76

2.27

1.2

1.4

—

Sequelae of infectious and parasitic diseases

2.56

2.27

2.0

1.7

—

Sequelae of infectious and parasitic diseases, including avohilmo

2.56

2.27

2.0

1.7

—

Conductive hearing loss, unspecified

2.56

2.27

1.3

1.6

—

Ocular pain

2.56

2.27

1.4

1.7

—

Obesity related asthma

262

1.60

2.25

1.4

1.6

—

Intestinal stricture

262

1.60

2.25

1.7

1.6

—

Abnormal weight loss

2.28

2.24

1.2

1.3

—

Disorders of lacrimal system

320

1.54

2.24

1.9

1.5

—

Other congenital malformations, including avohilmo

2.27

2.23

1.6

1.7

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4.53

2.23

1.3

1.2

—

Anxiety disorders, excluding more controls

404

1.39

2.23

2.0

1.5

—

ILD-related respiratory insufficiency

3.12

2.22

1.1

1.3

—

Continuous positive airway pressure

2.03

2.22

1.5

1.4

—

Other mycoses, not elsewhere classified/unspecified, including avohilmo

5.58

2.21

1.6

1.4

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

5.58

2.21

1.2

1.3

—

Pneumonitis due to solids and liquids

2.34

2.21

1.5

1.3

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2.05

2.21

1.3

1.6

—

Pediculosis, acariasis and other infestations

2.86

2.20

1.3

1.9

—

Other follicular disorders

2.69

2.20

1.8

1.9

—

Problems related to lifestyle

2.41

2.19

1.4

1.6

—

Caries of dentine, including avohilmo

322

1.40

2.19

1.7

1.5

—

Small fibre neuropathy

3.35

2.18

2.4

1.4

—

Early onset COPD

165

1.76

2.18

1.8

1.6

—

Benign neoplasm: Skin of trunk

3.34

2.18

1.5

1.4

—

Papulosquamous disorders

320

1.53

2.17

1.6

—

Stomatitis and related lesions

136

1.84

2.17

1.7

1.6

—

Fracture of foot, except ankle

158

1.77

2.16

1.6

1.4

—

Persons encountering health services in circumstances related to reproduction

305

0.57

2.16

1.2

1.6

—

Other disorders of patella

101

1.98

2.15

1.3

1.6

—

Idiopathic pulmonary fibrosis

2.30

2.14

1.8

1.3

—

Cardiomyopathies, Primary/intrinsic

2.30

2.14

1.2

1.6

—

Cardiomyopathy (excluding other)

2.30

2.14

1.2

1.6

—

Sequelae of other external causes

2.78

2.13

2.0

1.5

—

Congenital malformations of the urinary system, including avohilmo

2.78

2.13

1.4

1.6

—

Neurotic, stress-related and somatoform disorders

464

1.37

2.13

2.0

1.5

—

Spondylopathies (FG)

2.10

2.12

1.5

1.7

—

Deforming dorsopathies

189

1.69

2.12

1.4

1.6

—

Disorders of refraction and accommodation

181

1.71

2.11

1.8

1.5

—

Malignant melanoma

2.21

2.10

2.1

1.6

—

Type 1 diabetes, wide definition

123

1.87

2.10

1.3

1.5

—

Major coronary heart disease event excluding revascularizations

345

1.42

2.09

1.6

1.5

—

Other and unspecified follicular disorders

3.21

2.09

2.1

1.6

—

Infections with a predominantly sexual mode of transmission

152

1.77

2.09

1.5

—

Unknown and unspecified causes of morbidity

3.21

2.09

1.4

—

Other retinal disorders

431

1.39

2.09

1.6

1.5

—

Anxiety disorders

470

1.36

2.07

2.0

1.5

—

Hypoglycaemia, other or unspecified

2.56

2.07

1.4

1.3

—

Sicca syndrome [Sjögren]

2.56

2.07

1.7

1.6

—

Seborrhoeic dermatitis

2.26

2.07

1.5

1.6

—

Viral agents as the cause of diseases classified to other chapters

5.02

2.07

2.2

1.5

—

Oesophageal varices

2.91

2.07

1.8

1.3

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

2.91

2.07

1.8

1.2

—

Polyarthrosis

124

1.82

2.06

1.4

1.7

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

103

1.94

2.04

1.9

1.6

—

Viral hepatitis, IBD co-morbidity

4.01

2.04

1.3

—

therapeutic use

3.09

2.01

3.5

1.3

—

Intestinal malabsorption

3.09

2.01

1.6

1.5

—

Malignant melanoma, including Hilmo

2.05

2.00

2.2

1.5

—

Malignant neoplasm of pancreas, including Hilmo

2.64

2.00

1.1

1.4

—

Hypopituitarism

2.64

2.00

1.7

—

Other condition

1.96

1.99

1.8

1.6

—

N06DA Anticholinesterases

252

0.52

1.98

1.2

1.5

—

Use of anticholinesterases

252

0.52

1.98

1.2

1.5

—

Neuromuscular dysfunction of bladder

2.28

1.97

1.3

1.5

—

Amputation of thigh

3.34

1.96

1.9

1.4

—

Cholecystectomy

482

1.37

1.96

1.9

1.5

—

Emphysema

2.36

1.95

1.8

1.4

—

Rheumatism, unspecified

1.98

1.94

1.4

1.6

—

Other external causes of accidental injury

323

1.37

1.94

1.3

1.6

—

Postzoster neuralgia

4.57

1.94

1.8

1.5

—

Primary Sclerosing Cholangitis, IBD and UDCA required

4.56

1.94

1.4

1.3

—

Malignant neoplasm of other connective and soft tissue

4.56

1.94

1.6

1.3

—

Hyperprolactinaemia

4.56

1.94

2.2

1.6

—

Eustachian salpingitis and obstruction

2.57

1.94

1.4

1.8

—

Orthopaedic devices associated with adverse incidents

3.77

1.94

1.0

1.4

—

Malignant neoplasm of head and neck

2.57

1.94

1.9

1.6

—

Hypocalcemia

3.77

1.93

1.3

1.4

—

Secondary right heart disease

2.97

1.93

1.0

1.3

—

Polycythaemia vera

3.76

1.93

2.0

1.3

—

Scabies

2.97

1.93

1.3

1.7

—

Crohn disease (strict definition, all UC cases excluded)

2.97

1.93

1.8

1.7

—

Nonsuppurative otitis media

103

1.85

1.93

1.3

1.6

—

Barrett oesophagus

2.73

1.93

1.7

1.6

—

Otitis externa, unspecified

2.12

1.92

2.9

1.7

—

Injuries to the head

119

545

1.29

1.91

1.5

1.6

—

Ankylosing spondylitis, strict definition

3.19

1.88

1.4

1.8

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

3.19

1.88

1.9

1.3

—

Cyst of kidney

2.31

1.87

2.6

1.4

—

Malignant neoplasm of bronchus and lung, including Hilmo

1.90

1.87

1.6

1.5

—

Polyuria

174

1.67

1.85

2.1

1.6

—

Other abnormal uterine and vaginal bleeding

1.82

1.85

1.7

1.5

—

Essential (haemorrhagic) thrombocythaemia

3.54

1.84

1.5

1.2

—

Viral encephalitis, not elsewhere classified/unspecified

4.19

1.82

1.4

1.3

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

4.19

1.82

1.4

1.3

—

Malignant neoplasm of breast, ER-negative, including Hilmo

2.02

1.82

1.4

1.5

—

Injuries to the thorax

417

1.41

1.81

1.3

1.6

—

Ulcerative colitis (strict definition, require KELA)

108

1.85

1.81

2.0

1.5

—

Gastric ulcer

130

1.77

1.81

1.7

1.6

—

Other specified/unspecified bacterial intestinal infections

2.58

1.80

2.7

1.4

—

Other epidermal thickening

3.05

1.80

1.9

1.4

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

3.05

1.80

2.0

1.3

—

Arterial embolism and thrombosis of lower extremity artery

3.05

1.80

1.0

1.4

—

Mixed conductive and sensorineural hearing loss

1.96

1.79

1.2

1.6

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1.96

1.79

1.5

1.7

—

Meningitis

2.76

1.79

1.6

—

Spontaneous abortion

149

0.45

1.78

1.3

1.7

—

Pregnancy with abortive outcome

188

1.47

1.78

1.5

1.6

—

Injuries to the hip and thigh

367

1.42

1.78

1.5

1.6

—

Benzodiazepine use

107

558

1.29

1.77

1.7

1.5

—

Nonorganic sleeping disorders, excluding more controls

109

1.84

1.76

1.4

—

Other endocrine disorders

3.39

1.76

1.2

1.4

—

Other crystal arthropathies

3.35

1.75

1.7

1.2

—

Morphin

3.35

1.75

1.3

1.4

—

Malignant neoplasm of small intestine, including Hilmo

3.34

1.75

1.2

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

3.34

1.74

1.7

1.2

—

Impetigo

3.34

1.74

1.7

1.5

—

Other maternal disorders predominantly related to pregnancy

188

0.53

1.74

1.3

1.6

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

343

1.45

1.73

1.8

1.5

—

Prolonged pregnancy

0.00

1.72

0.0

1.8

—

Other headache syndromes

256

1.52

1.72

1.2

1.6

—

Other other unspecified disorders of the circulatory system

2.93

1.72

1.1

1.4

—

Convalescence

2.92

1.72

1.1

1.5

—

Malignant neoplasm of thyroid gland, including Hilmo

2.92

1.72

2.0

1.6

—

Other enthesopathies

225

1.56

1.72

1.3

1.6

—

Acute nephritic syndrome

3.86

1.71

3.4

1.5

—

Viral agents as the cause of diseases classified to other chapters, including avohilmo

3.86

1.71

2.2

1.5

—

Coxarthrosis [arthrosis of hip](FG)

277

1.42

1.69

1.2

1.6

—

Accidents

323

1.33

1.69

1.4

1.6

—

Open wound of head

461

1.37

1.68

1.8

1.5

—

Benign neoplasm of colon, rectum, anus and anal canal

494

1.33

1.68

1.5

—

Type 1 diabetes

156

1.67

1.2

1.5

—

Deviated nasal septum

283

1.48

1.67

1.3

1.6

—

Nerve, nerve root and plexus disorders

114

537

1.27

1.67

1.4

1.6

—

Postpartum haemorrhage due to anatomy

3.16

1.66

1.7

1.5

—

Other specified disorders of external ear

2.59

1.66

1.4

1.5

—

COPD, hospital admissions 1, only main diagnosis

257

1.47

1.65

1.7

1.6

—

Falls/tendency to fall

112

438

1.28

1.65

1.5

1.6

—

Benign neoplasm: Other and unspecified parts of mouth

2.81

1.65

1.6

—

Postprocedural disorders of digestive system, not elsewhere classified

2.81

1.65

1.6

1.4

—

Other benign neoplasms of uterus

2.81

1.65

3.3

1.4

—

Other intervertebral disc disorders

373

1.33

1.63

1.5

1.6

—

Dronedarone medication

3.58

1.61

1.2

1.4

—

Covid-19 suspected case

120

1.75

1.61

1.2

1.5

—

Other aneurysm

2.39

1.61

1.3

1.4

—

Juvenile arthritis (FINNGEN)

3.58

1.61

1.0

1.7

—

Other diseases of blood and blood-forming organs

2.39

1.61

1.3

1.5

—

Non-small cell lung cancer, including Hilmo

2.02

1.61

1.7

1.3

—

Peripheral arterial reconstruction

143

1.68

1.60

1.5

—

Unspecified jaundice

2.51

1.59

3.3

1.4

—

Scleritis and episcleritis

2.50

1.59

2.0

1.9

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

2.50

1.59

1.6

1.7

—

malignant neoplasm of male genital organs, including Hilmo

121

1.59

1.4

1.5

—

FESS (DNB20)

1.91

1.59

1.4

1.6

—

Infective dermatitis

2.00

1.59

1.2

1.6

—

Calculus of lower urinary tract

2.33

1.58

1.5

1.3

—

Malignant neoplasm of head and neck, including Hilmo

2.33

1.58

1.9

1.8

—

Other and unspecified acute skin changes due to ultraviolet radiation

3.01

1.58

1.8

1.3

—

Ulcerative ileocolitis

3.01

1.58

2.8

1.4

—

Attention to artificial openings

3.01

1.58

1.2

1.5

—

Extreme obesity with alveolar hypoventilation

2.70

1.58

1.4

1.5

—

Inflammatory disorders of breast

2.70

1.58

3.7

1.9

—

Colorectal cancer

116

1.74

1.57

1.1

1.5

—

Paracetamol or NSAID medication

1.84

1.56

1.4

1.6

—

Thyroiditis

2.28

1.55

1.4

1.6

—

Otitis externa

160

1.63

1.55

2.2

1.6

—

Herpesviral [herpes simplex] infections, including avohilmo

160

1.63

1.55

1.6

1.5

—

Biomechanical lesions, not elsewhere classified

2.43

1.53

1.4

1.6

—

Nonspecific lymphadenitis

2.43

1.53

1.6

2.0

—

Other symptoms and signs involving the circulatory and respiratory systems

2.43

1.53

1.0

1.3

—

Malignant neoplasm of respiratory system and intrathoracic organs

1.79

1.53

1.5

1.6

—

Malignant neoplasm of colon, including Hilmo

1.88

1.52

1.1

1.6

—

Chondrocostal junction syndrome [Tietze]

3.34

1.52

1.8

1.5

—

Haemorrhage, not elsewhere classified

3.34

1.52

1.0

1.4

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

2.07

1.52

1.6

1.5

—

Residual foreign body in soft tissue

0.00

1.52

0.0

1.6

—

Episcleritis

2.60

1.51

2.1

2.0

—

Atrial septal defect

3.32

1.51

1.4

1.5

—

Malignant neoplasm of endocrine gland, including Hilmo

2.60

1.51

2.0

1.6

—

Chronic periodontitis, complicated

497

1.33

1.51

1.8

1.5

—

Other acute skin changes due to ultraviolet radiation

2.86

1.50

1.8

1.3

—

Malignant neoplasm of mesothelium and soft tissue

2.86

1.50

1.5

1.2

—

Hyperfunction of pituitary gland

2.86

1.50

2.3

1.6

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

2.16

1.50

3.0

1.5

—

Diabetic retinopathy, excluding more controls

110

1.58

1.49

1.7

1.6

—

Acute pancreatitis (for exclusion)

154

1.62

1.49

1.7

1.5

—

Reactive arthropathies

2.07

1.49

1.3

1.6

—

Dermatophytosis

101

1.78

1.48

1.4

1.5

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

2.15

1.48

1.2

1.8

—

Malignant neoplasm of breast, HER-negative

1.95

1.48

1.5

—

Mental retardation, excluding more controls

3.22

1.47

1.0

1.5

—

Diseases of salivary glands

243

1.48

1.46

1.7

1.5

—

Ethmoidectomy

1.84

1.45

1.4

1.6

—

Crohn's disease of small intestine

2.37

1.45

2.1

1.7

—

Other/unspecified disorders of vestibular function

2.51

1.45

1.1

1.5

—

Corneal ulcer

117

1.71

1.44

1.6

—

Viral and other specified intestinal infections

1.84

1.44

1.3

—

Open wound of ankle and foot

1.92

1.43

1.9

1.5

—

Bacterial meningitis

2.73

1.43

1.3

1.4

—

Disorders of orbit

2.73

1.43

1.7

1.4

—

Unspecified chronic bronchitis

2.73

1.43

1.5

1.4

—

Flat foot [pes planus] (acquired)

2.04

1.43

1.3

1.6

—

Unspecified misadventure during surgical and medical care

2.31

1.43

4.8

1.5

—

Long labour

1.83

1.40

1.4

1.6

—

Other symptoms and signs involving the digestive system and abdomen

103

1.75

1.40

1.5

1.7

—

Allergic urticaria

2.25

1.40

1.7

1.8

—

Myocardial infarction, without ST-elevation

342

1.37

1.39

1.5

1.6

—

Pustular psoriasis

2.42

1.39

1.1

1.6

—

Urticaria

181

1.55

1.39

1.6

—

Use of pramipexole

180

0.50

1.38

1.7

1.6

—

Bacterial, viral and other infectious agents

2.08

1.38

2.4

1.6

—

Nonsuppurative otitis media, including avohilmo

156

1.55

1.38

1.3

1.6

—

Suggestive for eosinophilic asthma

2.00

1.38

1.4

1.7

—

Viral and other specified intestinal infections, including avohilmo

129

1.64

1.37

1.5

1.4

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

119

1.68

1.37

2.0

1.5

—

Carcinoma in situ of skin of upper limb, including shoulder

2.62

1.37

1.5

1.3

—

Arterial embolism and thrombosis

2.20

1.36

1.2

1.5

—

Varicella [chickenpox]

2.61

1.36

1.2

1.8

—

Other and unspecified iridocyclitis

2.61

1.36

1.3

1.5

—

Other retinal artery occlusion

2.95

1.36

1.2

1.4

—

Other congenital malformations of skin

2.95

1.36

1.8

1.5

—

Scar conditions and fibrosis of skin

2.95

1.36

1.2

1.5

—

Malignant neoplasm of oral cavity

2.95

1.36

2.0

1.2

—

Disorders of vestibular function (Vertigo)

364

1.36

1.34

1.4

1.6

—

Other local infections of skin and subcutaneous tissue

1.87

1.34

1.7

—

Arthropathic psoriasis

1.87

1.34

2.5

1.7

—

Acute pancreatitis

159

1.57

1.34

1.7

1.6

—

Epilepsy

231

1.47

1.34

1.6

—

Nonorganic sleeping disorders

120

1.67

1.33

1.4

1.6

—

Other diseases of stomach and duodenum

2.13

1.33

1.5

1.3

—

Scoliosis

2.15

1.33

1.0

1.3

—

Presbycusis

111

1.69

1.33

1.1

1.4

—

Pleural plaque

1.91

1.33

1.6

1.4

—

Bacterial, viral and other infectious agents, including avohilmo

2.04

1.32

2.4

1.6

—

Other disorders of glucose regulation and pancreatic internal secretion

2.04

1.32

1.4

—

Other diseases of lip and oral mucosa

316

1.39

1.32

1.8

1.6

—

Fracture of femur

187

1.49

1.31

1.6

—

Internal derangement of knee

255

1.44

1.31

1.5

1.6

—

Somatoform disorder

1.74

1.30

1.9

1.4

—

Acute peritonitis

2.10

1.30

1.3

1.4

—

Leisure time condition

129

1.63

1.29

1.3

1.5

—

Malignant neoplasm of pancreas

2.36

1.29

1.1

1.2

—

Depression or dysthymia

307

1.30

1.28

1.7

1.6

—

Fissure and fistula of anal and rectal regions

169

1.54

1.28

1.6

1.7

—

Sub-endpoint used in defining T1D endpoints

190

1.50

1.28

1.3

1.6

—

Mental retardation

2.76

1.27

1.0

1.4

—

Other pulmonary heart/vessel disease

2.29

1.27

1.0

1.4

—

Ulcerative proctitis

2.29

1.26

2.4

1.5

—

Mental and behavioural disorders due to sedatives or hypnotics

2.29

1.26

1.6

1.7

—

Varicose veins

369

1.31

1.26

1.5

—

Substance abuse, excluding more controls

388

1.31

1.25

1.3

1.5

—

malignant neoplasm of male genital organs

120

1.51

1.24

1.5

—

Clear cell adenocarcinoma of kidney

2.40

1.24

1.2

—

Contraceptive management

196

0.61

1.24

1.3

1.7

—

Carcinoma in situ, bladder

2.23

1.24

2.0

1.4

—

Appendectomy

452

1.31

1.24

2.0

1.6

—

Other diseases of anus and rectum

227

1.45

1.23

1.6

1.7

—

Hypotension

139

1.58

1.22

1.3

1.5

—

Spinal stenosis

317

1.33

1.22

1.5

—

Mental and behavioural disorders due to psychoactive substance use

476

1.29

1.22

1.4

1.6

—

Other benign neoplasm of uterus: Other parts/unspecified

2.64

1.21

2.2

1.3

—

Adenocarcinoma and ductal carcinoma of pancreas

2.64

1.21

1.0

1.2

—

Papillary adenocarcinoma of thyroid gland

2.64

1.21

2.2

1.6

—

Mental retardation, wide definition

2.61

1.20

1.0

1.4

—

Other hearing loss

222

1.44

1.20

1.7

1.6

—

Lumbar disc prolapse

365

1.30

1.20

1.5

1.6

—

Certain conditions originating in the perinatal period

2.61

1.19

1.6

1.4

—

Polyarthritis, unspecified

2.31

1.18

1.5

1.7

—

Malignant neoplasm of prostate, including Hilmo

119

1.49

1.18

1.4

1.5

—

Other disorders of bone

117

1.63

1.17

1.7

1.5

—

Gonarthrosis,primary

102

501

1.23

1.17

1.4

1.6

—

Myocardial infarction, strict

282

1.33

1.17

1.6

1.5

—

Diabetes mellitus in pregnancy

0.43

1.16

1.2

1.6

—

Primary angle-closure glaucoma

0.00

1.16

0.0

1.4

—

Use of rivastigmine

129

0.46

1.15

1.2

1.4

—

Rheumatic fever incl heart disease

2.51

1.15

1.0

1.5

—

Status epilepticus

2.50

1.15

2.6

1.4

—

Corns and callosities

2.05

1.15

1.1

1.5

—

Entropion and trichiasis of eyelid

1.81

1.15

2.2

1.3

—

Other symptoms and signs involving the urinary system

1.81

1.15

1.3

1.5

—

Other disorders of the genitourinary system

1.73

1.15

1.4

—

Lesion of plantar nerve

0.00

1.14

0.0

1.6

—

Myopia

1.85

1.13

1.3

1.7

—

454

1.28

1.13

1.3

1.6

—

Exposure to other specified factors

566

1.24

1.12

1.6

—

Special screening examination for infectious and parasitic diseases

1.68

1.12

1.9

1.3

—

Pediculosis, acariasis and other infestations, including avohilmo

103

1.65

1.12

1.2

1.6

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

2.34

1.12

1.6

1.2

—

Alcohol abuse, main dg

113

0.44

1.12

1.4

1.6

—

Diabetic retinopathy

195

1.37

1.12

1.6

—

Soft tissue disorders

100

418

1.22

1.11

1.6

1.5

—

Other and unspecified urticaria

119

1.60

1.11

1.4

1.6

—

Hypercalcemia

2.26

1.10

1.7

1.5

—

Infections with a predominantly sexual mode of transmission, including avohilmo

183

1.45

1.10

1.8

1.6

—

Presence of other devices

157

1.50

1.09

1.8

1.5

—

Amputation of foot

2.39

1.09

1.6

1.4

—

Hypogonadotropic hypogonadism

2.39

1.09

2.2

2.0

—

Malignant neoplasm of ovary, including Hilmo

2.38

1.09

1.4

1.6

—

Malignant neoplasm of oral cavity, including Hilmo

2.38

1.09

2.0

1.2

—

Varicose veins of other sites

1.95

1.08

2.0

1.7

—

Vascular disorders of the intestines

1.95

1.08

1.5

1.3

—

Propionic acid derivatives

149

0.64

1.08

1.4

1.7

—

Pure hypercholesterolaemia

402

1.25

1.08

1.7

1.5

—

Personal history of other diseases and conditions

2.18

1.07

1.4

1.5

—

Striking against or struck by other objects

252

1.39

1.07

1.6

—

Other hammer toe(s) (acquired)

102

1.61

1.06

1.5

1.6

—

Other neurological diseases

494

1.24

1.06

1.5

—

Postprocedural musculoskeletal disorders, not elsewhere classified

1.93

1.06

1.5

1.4

—

Diplopia

105

1.62

1.05

1.7

1.4

—

Tubulo-interstitial nephritis, not specified as acute or chronic

2.12

1.05

2.4

1.4

—

Seborrhoeic keratosis

186

1.45

1.05

2.0

1.5

—

Other (not insulin) diabetes medications

457

1.22

1.05

1.7

1.5

—

Parkinson's disease, strict definition

123

0.49

1.04

1.0

1.5

—

L02BG Aromatase inhibitors

176

1.46

1.04

1.3

1.5

—

Mood disorders, excluding more controls

448

1.22

1.03

1.7

1.5

—

Carcinoma in situ of skin of scalp and neck

2.28

1.03

1.4

—

Other salmonella infections, including avohilmo

2.28

1.03

1.0

1.6

—

Presbyopia

1.96

1.03

3.0

1.7

—

Use of donepezil

170

0.56

1.03

1.2

1.4

—

Personal history of malignant neoplasm

2.06

1.02

1.4

—

Malignant neoplasm of rectum, including Hilmo

1.83

1.02

1.3

1.6

—

Substance use, excluding alcohol

122

1.56

1.02

1.6

1.5

—

Acute pharyngitis

1.77

1.01

1.2

1.4

—

465

1.25

1.01

1.3

1.6

—

Scabies, including avohilmo

1.69

1.01

1.2

1.7

—

Other diseases of oesophagus

1.77

1.00

1.1

1.5

—

Tinnitus

180

1.45

1.00

1.4

1.7

—

Superficial injury of abdomen, lower back and pelvis

1.62

0.99

1.5

1.6

—

Macular hole

1.84

0.98

1.4

1.3

—

Metatarsalgia

1.81

0.98

1.4

1.5

—

Other specified disorders of kidney and ureter

2.18

0.98

2.2

1.3

—

Other secondary coxarthrosis

2.18

0.98

1.2

1.5

—

Medial epicondylitis

2.18

0.98

1.0

1.4

—

Melanocytic naevi of lower limb, including hip

2.18

0.98

1.6

—

Other disorders of pigmentation

2.18

0.98

1.4

1.3

—

Intermittent heterotropia

2.17

0.98

1.0

1.5

—

Haemorrhage in early pregnancy

132

0.51

0.97

1.0

1.6

—

Alcoholic liver disease

1.67

0.97

1.4

1.6

—

Disorders of the thyroid gland

505

1.21

0.97

1.7

1.5

—

Disorders of skin appendages

351

1.30

0.97

1.9

1.5

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

1.63

0.97

1.9

1.5

—

Other inflammation of eyelid, including avohilmo

301

1.33

0.96

1.7

1.5

—

Other and unspecified local infections of skin and subcutaneous tissue

1.74

0.96

1.6

1.7

—

Vitamin B12 deficiency anaemia

1.74

0.96

2.0

1.4

—

Malignant neoplasm of colon

1.74

0.96

1.0

1.6

—

Malignant neoplasm of prostate

116

1.43

0.95

1.5

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

242

1.36

0.94

1.6

—

Medical abortion

185

1.32

0.93

1.5

1.6

—

Other vitreous opacities

2.23

0.93

1.2

1.4

—

Varicella [chickenpox], including avohilmo

2.22

0.93

1.2

1.9

—

Adverse effects, not elsewhere classified

117

1.54

0.93

1.4

1.6

—

Complications predominantly related to the puerperium

120

0.50

0.93

1.8

1.6

—

Other enthesopathy of foot (+metatarsalgia)

1.72

0.92

1.4

1.5

—

Injury of muscle and tendon at shoulder and upper arm level

362

0.72

0.92

1.7

1.5

—

Later onset COPD

208

1.35

0.92

1.5

—

Unspecified urinary incontinence

1.82

0.92

1.6

—

Separation of retinal layers (serosa)

2.15

0.91

1.5

1.8

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

130

0.63

0.90

1.3

1.6

—

Benign neoplasm: Skin of eyelid, including canthus

118

1.53

0.90

1.7

1.4

—

Carcinoma in situ of skin

1.75

0.90

2.1

1.3

—

Kela-code for severe mental illness

255

0.67

0.90

1.2

1.6

—

Somnolence, stupor and coma

2.07

0.89

1.2

1.5

—

Other neurotic disorders

2.07

0.89

1.3

—

Atypical facial pain

2.07

0.89

2.0

1.4

—

Delivery, wide proxy

111

0.62

0.89

1.5

—

Schizophrenia

102

0.49

0.89

1.4

1.6

—

Other congenital malformations of skin, including avohilmo

1.86

0.87

1.9

1.7

—

Chondropathies

1.58

0.87

1.7

1.6

—

Parkinson's disease

131

0.53

0.87

1.0

1.5

—

Use of biperiden

2.00

0.87

1.2

1.8

—

Multiple gestation

2.00

0.87

1.3

1.9

—

Coxarthrosis

259

1.27

0.86

1.2

1.6

—

Otalgia

1.82

0.85

1.3

1.7

—

Angina pectoris

320

1.24

0.85

1.3

1.5

—

Superficial injury of thorax

112

1.52

0.84

1.5

1.6

—

Glucosamine medication

309

1.27

0.83

1.5

1.6

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.71

0.83

1.5

1.7

—

Colon adenocarcinoma, helper endpoint

111

0.54

0.83

1.0

1.4

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

478

1.19

0.83

1.9

1.6

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

129

1.47

0.83

1.7

—

Unspecified mental disorder

285

0.70

0.83

1.3

1.6

—

Diabetic neuropathy

1.56

0.82

1.4

1.8

—

Pleural plaque with presence of asbestos

1.69

0.82

1.7

1.4

—

Melanocytic naevi

214

1.36

0.82

1.4

1.6

—

Other problems related to primary support group, including family circumstances

1.73

0.82

1.6

1.8

—

Other diseases of gallbladder

1.88

0.82

1.3

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mycobacterium sp identified in Blood by Organism specific culture

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS